Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo
Yuchen Tang(Soochow University), Wěi Li(First Affiliated Hospital of Xi'an Jiaotong University), Min Tao(Soochow University), Bairong Shen(Chinese Academy of Sciences), Lu Liu(Cangzhou Central Hospital), Yan Zhang(University of Missouri), Jin Zhou(Soochow University), Dongmei Gu(Tianjin Medical University General Hospital), Mengyao Wu(Soochow University), Meng Shen(Soochow University), Yuan Gao(Soochow University), Qiaoming Zhi(Soochow University), Mengdan Xu(Soochow University), Jie Yu(Zhejiang Chinese Medical University)
Cited by 116
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
HIF-1α pathway: role, regulation and intervention for cancer therapy
|Acta Pharmaceutica Sinica B|2015|1.9k
The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients
|Science Translational Medicine|2016|416
Multiple Reaction Monitoring of mTRAQ-Labeled Peptides Enables Absolute Quantification of Endogenous Levels of a Potential Cancer Marker in Cancerous and Normal Endometrial Tissues
|Journal of Proteome Research|2008|172
AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program
|The Journal of Experimental Medicine|2017|171